Clinical Trials Search Results - University of Colorado Hospital

Skip to Content

Clinical Trials Search Results

Search for

in

In Progress (9)

Showing 1-9 of 9

Sorted By:

A-Z
Z-A

GOG 0213 Phase III randomized controled clinical trial of carboplatin and paclitaxel alone or in combination with bevacizumab followed by bevacizumab and secondary cytoreductive surgery in platinum sensitive recurent ovarian peritoneal primary and fallopian TUV cancer
GOG 0258 A RANDOMIZED PHASE III TRIAL OF CISPLATIN AND TUMOR VOLUME DIRECTED IRRADIATION FOLLOWED BY CARBOPLATIN AND PACLITAXEL VS. CARBOPLATIN AND PACLITAXEL FOR OPTIMALLY DEBULKED, ADVANCED ENDOMETRIAL CARCINOMA
GOG 0267: QUALITY OF LIFE AND CARE NEEDS IN PATIENTS WITH PERSISTENT OR RECURRENT PLATINUM-RESISTANT OVARIAN, FALLOPIAN TUBE, AND PERITONEAL CANCER
GOG 0274: A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared To Chemoraditiaon Alone: The Outback Trial ( ANZGOG 0902)
GOG-0212 A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12, Monthly Cycles of Single Agent Paclitaxel or XyotaxT (CT-2103) (IND# 70177) Versus No Treatment Until Documented Relapse in Women With Advanced Ovarian or Primary Peritoneal Cancer Who Achieve a Complete Clinical Response to Primary Platinum / Taxane Chemotherapy
GOG-0241 A GCIG INTERGROUP MULTICENTER PHASE III TRIAL OF OPEN LABEL CARBOPLATIN AND PACLITAXEL +/- NCI-SUPPLIED AGENT: BEVACIZUMAB (NSC #704865, IND #7921) COMPARED WITH OXALIPLATIN AND CAPECITABINE +/- BEVACIZUMAB AS FIRST LINE CHEMOTHERAPY IN PATIENTS WITH MUCINOUS EPITHELIAL OVARIAN OR FALLOPIAN TUBE CANCER (MEOC)
GOG-0261 A RANDOMIZED PHASE III TRIAL OF PACLITAXEL PLUS CARBOPLATIN VERSUS IFOSFAMIDE PLUS PACLITAXEL IN CHEMOTHERAPY- NAIVE PATIENTS WITH NEWLY DIAGNOSED STAGE I-IV OR PERSISTENT OR RECURRENT CARCINOSARCOMA (MIXED MESODERMAL TUMORS) OF THE UTERUS
GOG-0262 A PHASE III TRIAL OF EVERY-3-WEEKS PACLITAXEL VERSUS DOSE DENSE WEEKLY PACLITAXEL IN COMBINATION WITH CARBOPLATIN WITH OR WITHOUT CONCURRENT AND CONSOLIDATION BEVACIZUMAB (NSC #704865, IND #7921) IN THE TREATMENT OF PRIMARY STAGE II, III OR IV EPITHELIAL OVARIAN, PERITONEAL OR FALLOPIAN TUBE CANCER and ACRIN 6695: PERFUSION CT IMAGING TO EVALUATE TREATMENT RESPONSE IN PATIENTS PARTICIPATING IN GOG-0262
Prospective Evaluation of Vaginal Stenosis and Sexual Function in Patients with Pelvic Malignancies Treated with Multimodality Therapy Including Radiation Therapy versus Surgery Alone

Showing trials 1-9 of 9